Bill
HR 10094
Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2026
119th Congress
Introduced by Greg Casar and 12 co-sponsors
The bill requires federal-funded biomedical products to have pricing agreements that limit U.S. prices to international reference prices and uses gov’t oversight to enforce afforda
Introduced in House